137 A phase I study of an oral vascular endothelial growth factor receptor-2 (VEGFR-2) tyrosine kinase inhibitor, CP-547,632, in patients with advanced solid tumors

,2008, 引用: 0

Cancer Chemotherapy and Pharmacology,2007, 引用: 24

Critical Reviews in Oncology Hematology,2007, 引用: 39

Journal of Chemotherapy,2004, 引用: 37

Journal of Internal Medicine,2003, 引用: 74

Annals of Oncology,2006, 引用: 4

Hematology-oncology Clinics of North America,2004, 引用: 4

European Journal of Cancer,2006, 引用: 360

,2005, 引用: 0

Biotechnology annual review,2006, 引用: 20